Isabella Franco1, Antonella Bianco1, Antonella Mirizzi1, Angelo Campanella1, Caterina Bonfiglio1, Paolo Sorino1, Maria Notarnicola2, Valeria Tutino2, Raffaele Cozzolongo3, Vito Giannuzzi3, Laura R Aballay4, Claudia Buongiorno1, Irene Bruno1, Alberto R Osella1. 1. Laboratory of Epidemiology and Biostatistics, National Institute of Gastroenterology, "S. de Bellis" Research Hospital, Castellana Grotte (Ba), Via Turi 27, 70013 Castellana Grotte, Italy. 2. Laboratory of Nutritional Biochemistry, National Institute of Gastroenterology, "S. de Bellis" Research Hospital, Castellana Grotte (Ba), Via Turi 27, 70013 Castellana Grotte, Italy. 3. Department of Gastroenterology, National Institute of Gastroenterology, "S. de Bellis" Research Hospital, Castellana Grotte (Ba), Via Turi 27, 70013 Castellana Grotte, Italy. 4. Human Nutrition Research Center (CenINH), School of Nutrition, Faculty of Medical Sciences, Universidad Nacional de Córdoba, Enrique Barros Pabellón Biología Celular, Ciudad Universitaria, Cordoba X5000, Argentina.
Abstract
BACKGROUND: Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common chronic liver disease worldwide, and lifestyle modification is the current standard treatment. The aim of the study was to estimate the effect of two different physical activity (PA) programs, a Low Glycemic Index Mediterranean Diet (LGIMD), and their combined effect on the NAFLD score as measured by FibroScan®. METHODS:Moderate or severe NAFLD subjects (n = 144) were randomly assigned to six intervention arms during three months. Interventions arms were a control diet, LGIMD, aerobic activity program (PA1), combined activity program (PA2), and LGIMD plus PA1 or LGIMD plus PA2. The data were compared at baseline, at 45 days, and at 90 days. Analysis of variance was performed under the intention-to-treat principle. RESULTS: There was a statistically significant reduction in the NAFLD score after 45 days of treatment in every working arm except for Arm 1 (control diet). After 90 days, the best results were shown by the intervention arms in which LGIMD was associated with PA: LGIMD plus PA1 (-61.56 95% CI -89.61, -33.50) and LGIMD plus PA2 (-38.15 95% CI -64.53, -11.77). CONCLUSION: All treatments were effective to reduce NAFLD scores, but LGIMD plus PA1 was the most efficient.
RCT Entities:
BACKGROUND:Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common chronic liver disease worldwide, and lifestyle modification is the current standard treatment. The aim of the study was to estimate the effect of two different physical activity (PA) programs, a Low Glycemic Index Mediterranean Diet (LGIMD), and their combined effect on the NAFLD score as measured by FibroScan®. METHODS: Moderate or severe NAFLD subjects (n = 144) were randomly assigned to six intervention arms during three months. Interventions arms were a control diet, LGIMD, aerobic activity program (PA1), combined activity program (PA2), and LGIMD plus PA1 or LGIMD plus PA2. The data were compared at baseline, at 45 days, and at 90 days. Analysis of variance was performed under the intention-to-treat principle. RESULTS: There was a statistically significant reduction in the NAFLD score after 45 days of treatment in every working arm except for Arm 1 (control diet). After 90 days, the best results were shown by the intervention arms in which LGIMD was associated with PA: LGIMD plus PA1 (-61.56 95% CI -89.61, -33.50) and LGIMD plus PA2 (-38.15 95% CI -64.53, -11.77). CONCLUSION: All treatments were effective to reduce NAFLD scores, but LGIMD plus PA1 was the most efficient.
Authors: M L Pollock; B A Franklin; G J Balady; B L Chaitman; J L Fleg; B Fletcher; M Limacher; I L Piña; R A Stein; M Williams; T Bazzarre Journal: Circulation Date: 2000-02-22 Impact factor: 29.690
Authors: Cora L Craig; Alison L Marshall; Michael Sjöström; Adrian E Bauman; Michael L Booth; Barbara E Ainsworth; Michael Pratt; Ulf Ekelund; Agneta Yngve; James F Sallis; Pekka Oja Journal: Med Sci Sports Exerc Date: 2003-08 Impact factor: 5.411
Authors: Angelo Campanella; Giovanni Misciagna; Antonella Mirizzi; Maria Gabriella Caruso; Caterina Bonfiglio; Laura R Aballay; Liciana Vas de Arruda Silveira; Antonella Bianco; Isabella Franco; Paolo Sorino; Claudia Buongiorno; Anna Maria Cisternino; Maria Notarnicola; Vito M B Guerra; Alberto R Osella Journal: Int J Epidemiol Date: 2021-03-03 Impact factor: 7.196
Authors: E Riboli; K J Hunt; N Slimani; P Ferrari; T Norat; M Fahey; U R Charrondière; B Hémon; C Casagrande; J Vignat; K Overvad; A Tjønneland; F Clavel-Chapelon; A Thiébaut; J Wahrendorf; H Boeing; D Trichopoulos; A Trichopoulou; P Vineis; D Palli; H B Bueno-De-Mesquita; P H M Peeters; E Lund; D Engeset; C A González; A Barricarte; G Berglund; G Hallmans; N E Day; T J Key; R Kaaks; R Saracci Journal: Public Health Nutr Date: 2002-12 Impact factor: 4.022
Authors: Kate Hallsworth; Gulnar Fattakhova; Kieren G Hollingsworth; Christian Thoma; Sarah Moore; Roy Taylor; Christopher P Day; Michael I Trenell Journal: Gut Date: 2011-06-27 Impact factor: 23.059
Authors: Hye Won Lee; Soo Young Park; Seung Up Kim; Jae Young Jang; Hana Park; Ja Kyung Kim; Chun Kyon Lee; Young Eun Chon; Kwang-Hyub Han Journal: PLoS One Date: 2016-06-10 Impact factor: 3.240
Authors: Tracy Bonsu Osei; Anne-Marieke van Dijk; Sjoerd Dingerink; Felix Patience Chilunga; Erik Beune; Karlijn Anna Catharina Meeks; Silver Bahendeka; Matthias Bernd Schulze; Charles Agyemang; Mary Nicolaou; Adriaan Georgius Holleboom; Ina Danquah Journal: Nutrients Date: 2021-10-20 Impact factor: 5.717
Authors: Elena Buzzetti; Audrey Linden; Lawrence Mj Best; Angela M Madden; Danielle Roberts; Thomas J G Chase; Suzanne C Freeman; Nicola J Cooper; Alex J Sutton; Dominic Fritche; Elisabeth Jane Milne; Kathy Wright; Chavdar S Pavlov; Brian R Davidson; Emmanuel Tsochatzis; Kurinchi Selvan Gurusamy Journal: Cochrane Database Syst Rev Date: 2021-06-11